Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

That a bank manager, of all people, could be fooled on a scale sufficient to bring down a bank is a sign of how sophisticated ...

This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for ...

It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...

Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the ...

The FDA communicated that it has applied a standard three-month extension from the original goal date of February 28, 2025. Eton believes it has fully addressed all questions from the FDA and there ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

As with climate change, why are we so slow to recognise the existential threat that drug use poses to humanity?

Learn more about whether Ultragenyx Pharmaceutical Inc. or Vericel Corporation is a better investment based on AAII's A+ ...

Researchers have developed a new material that could help to remove unwanted pollutants — including leftover medicines and ...

The use of march-in rights to target pricy drugs has been a controversial issue across several administrations.

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...